Regionshospitalet Hammel Neurocenter er et højtspecialiseret neurorehabiliteringshospital, der indgår i Hospitalsenhed Midt. Hospitalet behandler patienter, der har fået en moderat eller svær hjerneskade som følge af f.eks. blodprop i hjernen, hjerneblødning, ulykke og andre sygdomme i centralnervesystemet.

During the past decade, Regionshospitalet Hammel Neurocenter conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regionshospitalet Hammel Neurocenter" #1 collaborator was "Regionshospitalet Hammel Neurocenter" with 4 trials as a collaborator, "Aalborg University" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Hammel Neurorehabilitation Centre and University Research Clinic" with 1 trials as a collaborator and "Haukeland University Hospital" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Regionshospitalet Hammel Neurocenter" are "Brain Concussion" (2 trials), "Stroke" (2 trials), "Acquired Brain Injury" (1 trials), "Brain Injuries" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Regionshospitalet Hammel Neurocenter" in a lesser frequency.

Most popular intervention types in "Regionshospitalet Hammel Neurocenter" are "Behavioral" (3 trials), "Device" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional arm training" (1 trials), "Erigo® Hocoma" (1 trials), "GAIN 2.0" (1 trials), "Graded and behavevial theraphy" (1 trials) and "Methylphenidate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regionshospitalet Hammel Neurocenter" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Regionshospitalet Hammel Neurocenter". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regionshospitalet Hammel Neurocenter, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Regionshospitalet Hammel Neurocenter, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".